1999 to mid-2000s saw increase in seniors using prescription meds
Jul 09, 2024
Polypharmacy increased, peaking at 43.0% in 2017 to March 2020; hyperpolypharmacy increased during 1999-2000 to 2007-2008.
More seniors may be willing to take deprescribing advice
By
John Hall
Apr 12, 2024
Providers, however, must continue to check their motivation in cutting back on certain prescriptions, pharmacy experts caution.
Congress, CMS clash over AI role in Medicare claims denials
By
Aaron Dorman
Nov 07, 2023
Thirty House Democrats released a letter Friday urging CMS to take several steps to make sure AI is not unfairly denying coverage.
Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
Nirmatrelvir during acute SARS-CoV-2 does not reduce risk for long COVID
Jan 05, 2024
No association was seen for rebound symptoms or test positivity with symptoms of long COVID.
AI could play role in preventing prescribing of unnecessary drugs in older adults
By
Kristen Fischer
Apr 22, 2024
A new study finds that artificial intelligence could encourage doctors to stop prescribing drugs that aren’t necessary.
High-intensity statins underused with atherosclerotic cardiovascular disease
Sep 19, 2023
The authors say that the findings show gaps between practice and guideline-based care.
Company seeks FDA approval for MDMA as treatment for PTSD
Dec 13, 2023
“If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy, which we hope will drive additional investment into new research in mental health.”
Eli Lilly reports temporary shortage of Humalog and Insulin Lispro Injection
Mar 25, 2024
Products are expected to be out of stock at wholesalers and pharmacies through the beginning of April.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.